NSE - SMEListed
Bio Medica Laboratories Limited

Bio Medica Laboratories Limited

Company website
Check Allotment StatusWatch Live Market
Bio Medica Laboratories Limited — Issue: ₹37,72,000 cr, Fresh: ₹33,95,000 cr, OFS: ₹3,77,000 cr.
Total shares on offer: 1000. Apply from 21-05-2026 to 25-05-2026. Consider your investment horizon — IPOs can be volatile on listing day.
Start Date21-05-2026
End Date25-05-2026
Listing Date29-05-2026
Allotment Date26-05-2026
Current Price₹111.20
GMP-₹7 (-5.04%)
Lot Size1000 Shares
Subscription2.31 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹132 - ₹139
Pre Issue₹91,80,001
Post Issue₹1,25,75,001
Issue Size₹37,72,000
(aggregating up to 52.43 Cr)
Fresh Issue₹33,95,000
(aggregating up to 47.19 Cr)
Offer For Sale₹3,77,000
(aggregating up to 5.24 Cr)
Advertisement
The Grey Market Premium (GMP) for Bio Medica Laboratories Limited is currently around -₹7 (-5.04%). This indicates an estimated listing price of approximately ₹125 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
14 May 2026, 13:11
₹139
-₹7
₹132 (-5.04%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Bio Medica Laboratories Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPINov-25Mar-25Mar-24Mar-23
EPS
9.44
10.67
2.72
0.36
ROE
54.41
99.59
67.74
13.92
ROCE
23.24
48.20
29.92
10.16
RONW
0
0
0
0
PRE IPO(PE)
0
13.03
0
0
POST IPO(PE)
13.45
0
0
0

Subscription Details (No. of Shares)

The below shows how many shares were subscribed by each investor category in the Bio Medica Laboratories Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹0.50
7.98
15.96
FIIs
₹0
7.98
0.00
RETAIL
₹24.91
72.67
2.92
HNIs 2+
₹8.13
17.82
2.19
HNIs 10+
₹16.26
16.58
1.02
Total
₹49.80
115.05
2.31

Application Wise Breakup (Approx. no of Apps)

CategoryReservedAppliedTimes
QIB
0
6
0.00
NIB
0
457
0.00
RETAIL
896
2,614
2.92
HNIs(10L +)
390
35
0.09
HNIs (2-10L)
195
422
2.16
Total
1,481
3,071
2.07
The IPO reservation for Bio Medica Laboratories Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
QIB
0.95%
36,000
HNI
46.53%
17,55,000
RETAIL
47.51%
17,92,000
Market Maker
5.01%
1,89,000
TOTAL
100.00%
37,72,000

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail
2
2,000
₹2,78,000
0
sHNI
3
3,000
₹4,17,000
0
bHNI
8
8,000
₹11,12,000
0
Below you can find the official contact details of Bio Medica Laboratories Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 7314102751
Address: Plot No. 11B-11C, Sector-E, Sanwer Road Industrial Area, Industrial Estate (Indore), Indore, Madhya Pradesh, 452015

IPO Registrar

Name: Skyline Financial Services Private Limited
Phone: +912228511022
Advertisement